March 2, 2026 · Form 4 insider transaction
Matsuda Masaru sold 1,987 shares of Arcutis Biotherapeutics, Inc. at $25.70 per share, a transaction worth $51.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on June 5, 2025, by the Reporting Person, with a plan end date of September 4, 2026.